Literature DB >> 3929634

In vivo and in vitro effects of cyclosporin A on Trypanosoma cruzi.

R E McCabe, J S Remington, F G Araujo.   

Abstract

The in vivo and in vitro effects of cyclosporin A on T. cruzi were examined. Mice receiving 150 or 75 mg/kg/day of cyclosporin A and infected with T. cruzi 48 hr later had significantly higher parasitemias and earlier mortality than controls. Mice receiving cyclosporin A after infection had parasitemias similar to controls. Infections with both the reticulotropic Y and the miotropic CL strains of T. cruzi were enhanced by cyclosporin A. The in vitro replication of epimastigotes, but not the intracellular replication of amastigotes, in mouse macrophages was inhibited by 5 micrograms cyclosporin A/ml. Enhancement of the infection by cyclosporin A was not due to an effect on macrophages since the drug did not prevent development of activated macrophages capable of killing intracellular T. cruzi.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3929634     DOI: 10.4269/ajtmh.1985.34.861

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  11 in total

1.  Antischistosomal effect of cyclosporin A: cure and prevention of mouse and rat schistosomiasis mansoni.

Authors:  D Bout; D Deslèe; A Capron
Journal:  Infect Immun       Date:  1986-06       Impact factor: 3.441

2.  Cerebrospinal fluid macrophage response to experimental cryptococcal meningitis: relationship between in vivo and in vitro measurements of cytotoxicity.

Authors:  J R Perfect; M M Hobbs; D L Granger; D T Durack
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

3.  Cyclosporin A enhances elimination of intracellular L. major parasites by murine macrophages.

Authors:  C Bogdan; H Streck; M Röllinghoff; W Solbach
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

4.  Pure paraflagellar rod protein protects mice against Trypanosoma cruzi infection.

Authors:  R A Wrightsman; M J Miller; J L Saborio; J E Manning
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

5.  Cyclosporin A treatment of Leishmania donovani reveals stage-specific functions of cyclophilins in parasite proliferation and viability.

Authors:  Wai-Lok Yau; Thierry Blisnick; Jean-François Taly; Manuela Helmer-Citterich; Cordelia Schiene-Fischer; Olivier Leclercq; Jing Li; Dirk Schmidt-Arras; Miguel A Morales; Cedric Notredame; Daniel Romo; Philippe Bastin; Gerald F Späth
Journal:  PLoS Negl Trop Dis       Date:  2010-06-29

6.  Differential susceptibilities of mice genomically deleted of CD4 and CD8 to infections with Trypanosoma cruzi or Trypanosoma brucei.

Authors:  M E Rottenberg; M Bakhiet; T Olsson; K Kristensson; T Mak; H Wigzell; A Orn
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

7.  Gamma interferon suppresses acute and chronic Trypanosoma cruzi infection in cyclosporin-treated mice.

Authors:  R McCabe; S Meagher; B Mullins
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

8.  Effect of T-lymphocyte suppression on the parasite burden in Leishmania major-infected, genetically susceptible BALB/c mice.

Authors:  W Solbach; K Forberg; M Röllinghoff
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

9.  Dosage, timing, and route of administration of cyclosporin A and nonimmunosuppressive derivatives of dihydrocyclosporin A and cyclosporin C against Schistosoma mansoni in vivo and in vitro.

Authors:  L H Chappell; A W Thomson; G C Barker; S W Smith
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

Review 10.  A Functional Analysis of the Cyclophilin Repertoire in the Protozoan Parasite Trypanosoma Cruzi.

Authors:  Alina E Perrone; Natalia Milduberger; Alicia G Fuchs; Patricia L Bustos; Jacqueline Bua
Journal:  Biomolecules       Date:  2018-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.